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Background:Successful transition fromoocyte tozygote
depends on the timely degradation of oocyte proteins to
prepare for embryonic development. InC.elegans, degra-
dation of the oocyte protein MEI-1 depends on MBK-2,
a kinase that phosphorylates MEI-1 shortly after fertiliza-
tion during the second meiotic division.
Results: Here we report that precise timing of MEI-1
phosphorylation depends on the cell cycle-regulated
release of MBK-2 from the cortex. Prior to the meiotic
divisions, MBK-2 is tethered at the cortex by EGG-3,
an oocyte protein required for egg activation (see [1], ac-
companying paper in this issue). During the meiotic divi-
sions, EGG-3 is internalized and degraded in an APC/C
(anaphase-promoting complex/cyclosome)-dependent
manner. EGG-3 internalization and degradation corre-
late with MBK-2 release from the cortex and MEI-1
phosphorylation in the cytoplasm. In an egg-3 mutant,
MEI-1 is phosphorylated and degraded prematurely.
Conclusion: We suggest that successful transition
from an oocyte to a zygote depends on the cell cycle-
regulated relocalization of key regulators from the
cortex to the cytoplasm of the egg.
Introduction
In most animals, reproduction depends on fusion of
an oocyte with sperm to form a fertilized egg or zygote.
Progression from oocyte to zygote can be divided into
two phases: oocyte maturation and egg activation [2].
During maturation, fully-grown oocytes, arrested at the
end of prophase of meiosis I, are stimulated by extracel-
lular signals to reenter meiotic M phase and initiate the
meiotic divisions. Oocytes typically are ovulated during
that time and reach a second meiotic arrest point await-
ing fertilization [3]. Egg activation—in many species trig-
gered by sperm entry—stimulates the mature egg to
complete the meiotic divisions, form pronuclei, and initi-
ate mitosis [4]. Whereas egg activation traditionally has
been viewed as the critical step signaling the beginning
of development, accumulating evidence suggests that
oocyte maturation also sets in motion changes required
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oocytes, maturation triggers reorganization of the endo-
plasmic reticulum and degradation of many RNAs asso-
ciated with oocyte fate [5, 6]. In C. elegans, maturation
activates the turnover of oocyte proteins that, if allowed
to persist in the zygote, would interfere with embryo-
genesis [7]. Maturation also stimulates phosphorylation
of RNA polymerase II, suggesting a possible role in
transcriptional reactivation [8]. A major challenge is to
understand how these changes are activated and
coordinated with the meiotic divisions.
C. elegans oocyte maturation is stimulated by a
sperm-secreted factor that signals the oocyte closest
to the spermatheca to initiate the first meiotic division
[9]. The mature oocyte is ovulated into the spermatheca,
fertilized, and pushed out into the uterus where it com-
pletes the meiotic divisions and secretes an egg shell.
Oocytes that undergo maturation, but are not fertilized,
complete anaphase I but do not undergo the second
meiotic division, form polar bodies, or secrete an egg
shell [10]. These oocytes, however, still activate the deg-
radation of oocyte proteins (e.g., MEI-1 and OMA-1) that
need to be degraded for a smooth transition to embry-
onic development [7]. Degradation of MEI-1 and OMA-
1 depends on MBK-2 [11–13]. MBK-2 belongs to the
family of dual specificity YAK-related kinases (DYRK)
[14]. MBK-2 phosphorylates MEI-1 and OMA-1 directly
beginning in the second meiotic division, triggering their
degradation in zygotes [7, 15, 16]. The mechanisms that
specify the timing of MEI-1 and OMA-1 phosphorylation
by MBK-2 are not known. Fertilization is not required,
but progression through the first meiotic division is es-
sential and sufficient, suggesting a link between meiotic
progression and MBK-2 activation [7]. A GFP:MBK-2
fusion relocalizes from the egg cortex to the cytoplasm
after meiosis I, raising the possibility that cell cycle-
dependent internalization of MBK-2 is the critical trigger
[7]. In the present study, we provide support for this
hypothesis by identifying and characterizing EGG-3, an
oocyte protein essential for MBK-2 localization to the
cortex.
Results
EGG-3 Is Required for MBK-2 Localization
to the Egg Cortex
We identified F44F4.2 in an RNAi screen for genes re-
quired for MBK-2 localization to the cortex (Figure 1
and Experimental Procedures). F44F4.2 was identified
independently in a screen for genes required for egg ac-
tivation and named egg-3 (see [1], accompanying paper
in this issue). A GFP:EGG-3 fusion localizes in a pattern
similar to that reported for GFP:MBK-2 ([1], accompany-
ing paper; and Figure 1). Like GFP:MBK-2, GFP:EGG-3
is enriched on the cortex of oocytes and newly fertilized
zygotes. In anaphase of meiosis I, GFP:EGG-3 localizes
to discrete subcortical puncta, which become internal-
ized during the second meiotic division. GFP:EGG-3 is
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1546Figure 1. EGG-3 Is Required to Localize
GFP:MBK-2 to the Cortex
(A and B) Live wild-type (A) and egg-
3[F44F4.2](RNAi) (B) hermaphrodites expres-
sing GFP:MBK-2. Each figure shows a close-
up of the oviduct and uterus separated by the
spermatheca (asterisk). Oocytes (left) and
fertilized eggs (right) flank the spermatheca.
Punctate gut autofluorescence is visible
above the oocytes.
(C and D) Live wild-type (C) or mbk-2(pk1427)
(D) hermaphrodites expressing GFP:EGG-3.
Embryos lacking GFP:EGG-3 are outlined.
Note that localization and turnover of
GFP:EGG-3 in zygotes do not require mbk-2.degraded after the 2-cell stage, unlike GFP:MBK-2,
which remains present in the cytoplasm of all early blas-
tomeres (Figure 1).
To visualize EGG-3 and MBK-2 directly, we generated
antibodies to each protein (Experimental Procedures).
As predicted from the GFP fusions, we found that
endogenous MBK-2 and EGG-3 colocalize on the cor-
tex of growing oocytes (Figure 2A). The antibody that
we generated against MBK-2 recognizes MBK-2 only
weakly during the meiotic divisions (Figure S1B in the
Supplemental Data available online), preventing direct
colocalization studies in these stages. We found, how-
ever, that two MBK-2 fusions (GFP:MBK-2 and MBK-
2:HIS) colocalize with endogenous EGG-3 on the cortex
in metaphase I embryos (Figure 2B; Figure S1C) and in
discrete cytoplasmic puncta during the second meiotic
division (Figure 2C; Figure S1C). In 2-cell and later em-
bryos, EGG-3 was rarely detected, whereas GFP:MBK-
2 (Figure 1) and endogenous MBK-2 (Figure S1B and
data not shown) persisted in the cytoplasm of all blas-
tomeres and on P granules until at least the 20-cell
stage. Comparison of total EGG-3 levels to cytoplasmic
GFP:MBK-2 levels confirmed that degradation of EGG-3
correlates with increased GFP:MBK-2 in the cytoplasm
(Figure 2E).
We also examined MBK-2 and EGG-3 localizations in
mutants homozygous for deletions in the egg-3 or mbk-
2 genes (Experimental Procedures). In the egg-3 dele-
tion mutant tm1191, MBK-2 was cytoplasmic at all
stages (Figure S1A). In contrast, in the mbk-2 deletion
mutantpk1427 [11], EGG-3 remained cortical in oocytes,
localized to internal puncta during meiosis, and disap-
peared after the 2-cell stage as in wild-type (Figures
S1A and S1B). We conclude that, although MBK-2 de-
pends on EGG-3 for cortical localization, EGG-3 does
not depend on MBK-2 for its localization or turnover.EGG-3 and MBK-2 Form a Complex In Vivo
and In Vitro
EGG-3 encodes a putative protein tyrosine phosphatase
(PTP) that is missing critical catalytic residues in its pre-
dicted active site (see Discussion), suggesting a possi-
ble function as an ‘‘antiphosphatase’’ or scaffold [17,
18]. To test whether EGG-3 and MBK-2 interact in vivo,
we immunoprecipitated each protein from worm ex-
tracts. We detected EGG-3 in MBK-2 immunoprecipi-
tates and MBK-2 in EGG-3 immunoprecipitates (Figures
3A and 3B). EGG-3 immunoprecipitates did not contain
PAR-5 (Figure 3A), an abundant, cortically enriched pro-
tein [19], confirming that the EGG-3:MBK-2 interaction
is specific. GFP antibodies could immunoprecipitate
MBK-2 in extracts from worms expressing GFP:EGG-3
but not in extracts from worms expressing GFP alone
(Figure 3C). We conclude that EGG-3 and MBK-2 form
a complex in vivo.
To test whether the EGG-3:MBK-2 interaction is di-
rect, we expressed both proteins as GST and FLAG
fusions in E. coli. We found that GST:EGG-3-coupled
beads could pull down FLAG:MBK-2 from E. coli ex-
tracts and, conversely, that GST:MBK-2 could pull down
FLAG:EGG-3 (Figure 3D). GST alone interacted with
neither FLAG fusions, confirming the specificity of the
assay (Figure 3D). We conclude that EGG-3 and MBK-
2 interact directly in vitro.
MEI-1 Is Phosphorylated and Degraded Prematurely
in the Absence of EGG-3
To investigate the effect of EGG-3 on MBK-2 activity
in vivo, we monitored MBK-2 activity with an antibody
specific for MEI-1 phosphorylated on serine 92 (MEI-1-
Ser92P), the site of MBK-2 phosphorylation [7]. To max-
imize MEI-1-Ser92P levels, we depleted by RNAimel-26,
the E3 ligase subunit that targets MEI-1 for degradation
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1547Figure 2. MBK-2 and EGG-3 Colocalize In Vivo
(A) Oocytes costained with a-MBK-2 (A) and a-EGG-3 (A0) antibodies. Yellow indicates colocalization in the merged panel (A00).
(B–D) Embryos expressing GFP:MBK-2 costained with a-GFP (B–D) and a-EGG-3 (B0–D0). Yellow indicates colocalization in the merged panels
(B00–D00).
(E) Graph showing relative levels of EGG-3 and GFP:MBK-2 at different stages. Error bars represent standard deviation.[20]. As in wild-type, in mel-26(RNAi), low levels of MEI-
1-Ser92P are first detected in the cytoplasm during mei-
osis II and reach maximal levels after meiosis (Figure 4A).
In contrast, in egg-3(tm1191);mel-26(RNAi), high levels
of MEI-1-Ser92P could be detected as early as meta-
phase of meiosis I. Prominent staining was detected
both in the cytoplasm (6/7 eggs) and on the metaphase
I spindle (4/7 eggs) (Figures 4A and 4B), a pattern never
seen in mel-26(RNAi) alone (0/23 eggs) (Figures 4A and
4B) or in wild-type [7].
To determine whether premature phosphorylation
leads to premature degradation, we compared the deg-
radation kinetics of GFP:MEI-1 in wild-type and egg-
3(tm1191). In wild-type, GFP:MEI-1 levels remain steady
for w25–30 min after egg exit from the spermatheca
(Figures 4C and 4D), consistent with the essential func-
tion for MEI-1 during the meiotic divisions, which occur
during this time [21]. In contrast, in egg-3(tm1191) mu-
tants, GFP:MEI-1 levels started to decline immediatelyafter spermatheca exit, reaching background levels by
30 min (Figures 4C and 4D). MEI-1 degradation was
dependent on MBK-2 as shown by the fact that egg-
3(tm1191); mbk-2(RNAi) maintained GFP:MEI-1 (Fig-
ure S2). We conclude that in the absence of EGG-3,
MEI-1 is phosphorylated and degraded prematurely.
EGG-3 Inhibits MBK-2 during Meiosis I
Progression through the meiotic divisions is required for
MBK-2 relocalization to the cytoplasm and for timely
degradation of MEI-1 and other proteins that require
MBK-2 for degradation (e.g., the germ plasm compo-
nent POS-1) [7, 11]. mat-1(ax227) is a temperature-
sensitive allele in the CDC-27 subunit of the anaphase-
promoting complex/cyclosome (APC/C) [22, 23]). At
25C,mat-1(ax227) eggs are fertilized but arrest in meta-
phase of meiosis I with GFP:MBK-2 at the cortex
(Figure 5A) [7, 11] and GFP:MEI-1 and GFP:POS-1 in
the cytoplasm (Figures 5B, 5C, and 5G). To investigate
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(A and B) Whole worm extracts (input) were immunoprecipitated (IP) with a-EGG-3 (A) or a-MBK-2 (B) and immunoblotted (IB) with antibodies as
indicated. Rabbit IgG was used as a negative control IP antibody. Anti-PAR-5 was used as a negative control target protein in the anti-EGG-3 IP.
Input is 1/100th of the IP. Numbers indicate molecular weight markers (kDa).
(C) Extracts from worms expressing GFP or GFP:EGG-3 were immunoprecipitated with a-GFP and immunoblotted with antibodies as indicated.
Input is 1/100th of the IP. Arrow points to GFP and arrowhead points to GFP:EGG-3.
(D) Extracts from E. coli expressing FLAG-EGG-3 or FLAG-MBK-2 (input) were pulled down with glutathione-sepharose beads coupled to GST
alone, GST-MBK-2, or GST-EGG-3 and immunoblotted with a-FLAG. Input is 1/50th of the pull-down.whether the lack of MEI-1 and POS-1 degradation is due
to sequestration of MBK-2 at the cortex by EGG-3, we in-
activated EGG-3 inmat-1(ax227)mutants. We found that
RNAi depletion of EGG-3 in mat-1(ax227) caused (1)
GFP:MBK-2 to accumulate in the cytoplasm (Figure 5D)
and (2) GFP:MEI-1 and GFP:POS-1 to be degraded in the
arrested zygotes (Figures 5E–5G). We conclude that the
inability of mat-1(ax227) mutants to degrade MEI-1 and
POS-1 is due to negative regulation of MBK-2 by EGG-3.
EGG-3 could negatively regulate MBK-2 by inhibiting
its intrinsic activity or by limiting its access to sub-
strates. To distinguish between these possibilities, we
immunoprecipitated GFP:MBK-2 from wild-type and
mat-1(ax227) hermaphrodites and assayed for kinase
activity against a synthetic peptide (Experimental Pro-
cedures). We found that GFP:MBK-2 showed similar
activity whether immunoprecipitated from wild-type or
mat-1(ax227) extracts (Figure 5H). GFP:MBK-2 with
a mutation in the ATP binding site (K196R) had only
background activity, confirming the specificity of the
assay. To verify these results in vivo, we stained mat-
1(ax227);mel-26(RNAi) zygotes for MEI-1-Ser92P. We
observed MEI-1-Ser92P in 36/84 mat-1(ax227);mel-
26(RNAi) zygotes (Figure 5I). Remarkably, in all positive
zygotes, P-MEI-1 was strongest at the cortex. This pat-
tern was dependent on EGG-3: in 29/39 mat-1(ax227);
mel-26(RNAi);egg-3(RNAi) with positive MEI-1-Ser92P
staining, MEI-1-Ser92P was cytoplasmic and showedno cortical enrichment (Figure 5J). We conclude that
EGG-3 restricts active MBK-2 to the cortex during
meiosis I.
Cell-Cycle Dependence of GFP:EGG-3 Dynamics
During meiosis II, EGG-3 relocalizes to subcortical
puncta and EGG-3 levels drop such that EGG-3 is not
detected after the 2-cell stage (Figures 1, 2, and 6). To in-
vestigate whether EGG-3 dynamics depend on meiotic
progression, we examined GFP:EGG-3 under condi-
tions where meiotic M phase is blocked in zygotes
[mat-1(RNAi)] [22] or activated precociously in unfertil-
ized oocytes [wee-1.3(RNAi)] [24]. As expected, we
found that GFP:EGG-3 remains cortical and stable in
mat-1(RNAi) zygotes (Figure 6B) and relocalizes preco-
ciously to internal puncta in wee-1.3(RNAi) oocytes still
in the oviduct (Figure 6C). We conclude that, as for
MBK-2, EGG-3 dynamics are stimulated by meiotic pro-
gression. Furthermore, EGG-3 degradation depends on
the APC/C subunit mat-1.
EGG-3 Is a Likely APC/C Target
APC/C is a multisubunit E3 ligase that targets cell-cycle
regulators for degradation by the proteasome [25]. Sev-
eral APC/C recognition motifs have been described, in-
cluding the destruction or D box (core sequence: RxxL).
EGG-3 contains six RxxL motifs (Figure 7A). Mutating
each motif revealed that the first two (D boxes 1 and 2)
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1549Figure 4. egg-3 Mutants Phosphorylate and Degrade MEI-1 Prematurely
(A) Dissected gonads fixed and stained with a-MEI-1-Ser92P (red) and DAPI (blue). mel-26(RNAi) blocks MEI-1-Ser92P degradation. Arrow
marks the meiosis I spindle/chromosome complex. Asterisk marks the spermatheca. Note precocious appearance of MEI-1-Ser92P in meta-
phase I in the egg-3 homozygous mutant (bottom). In this example, MEI-1-Ser92P could be detected in both the cytoplasm and on the meiotic
spindle.
(B) Metaphase I embryos of the indicated genotypes at higher magnification. Meiotic stage was determined by DAPI staining. Six DAPI-positive
bivalents are visible in metaphase I. egg-3 mutants undergo two meiotic divisions as in wild-type except that they do not extrude polar bodies,
resulting in 12 individualized chromosomes visible in metaphase II (see [1], accompanying paper). In this example, MEI-1-Ser92P was predom-
inantly cytoplasmic and was not enriched on the spindle.
(C) GFP:MEI-1 intensity in newly ovulated eggs in wild-type and egg-3(tm1191) mutants plotted with respect to minutes since exit from sperma-
theca. For each time point, GFP:MEI-1 intensity in the ovulated egg was calculated as a fraction of GFP:MEI-1 intensity in an unovulated oocyte in
the same hermaphrodite to correct for GFP fluorescence bleaching over time. Note that cytoplasmic GFP:MEI-1 decreases in both wild-type and
egg-3(tm1191) immediately after ovulation into the spermatheca resulting from accumulation of GFP:MEI-1 on the first meiotic spindle. Error
bars represent standard error of measurement (SEM).
(D) Live gonads from wild-type and egg-3(tm1191) hermaphrodites expressing GFP:MEI-1. Time is measured relative to spermatheca exit.are required for degradation (Figures 7B and 7C). Muta-
tions in D boxes 1 and 2 did not disrupt the cortical
or puncta localization of GFP:EGG-3 but caused
GFP:EGG-3 to persist past the 2-cell stage in the cyto-
plasm and on the cortex of all blastomeres (Figure 7C).
Mutations in other RxxL motifs located within or near
the PTP domain blocked GFP:EGG-3’s ability to localize
to the cortex but did not affect degradation (Figure 7B),
indicating that localization to the cortex is not a prerequi-
site for degradation. Western analysis confirmed that
all fusion proteins were expressed at similar levels (Fig-
ure 7D), ruling out overexpression as a possible cause
for the degradation defects. EGG-3 degradation was
also blocked when the proteasome subunit rpn-7 was
partially inactivated by RNAi (75% of rpn-7(RNAi) her-
maphrodites [n = 35] had 2-cell or older embryos with
cortical EGG-3) (Figure 7C). We conclude that EGG-3
is likely to be targeted for degradation by APC/C and
to be degraded by the proteasome.
If EGG-3 degradation were the only factor contributing
to MBK-2 release in the cytoplasm, GFP:MBK-2 shouldalso localize to cell cortices in rpn-7(RNAi) embryos. In
contrast, we found that GFP:MBK-2 remained cytoplas-
mic in most rpn-7(RNAi) embryos (Figure 7C). Cortical
GFP:MBK-2 was not detected in 4-cell and older em-
bryos in 95% of hermaphrodites examined (n = 49). In
the remaining 5% of hermaphrodites examined, faint
cortical GFP:MBK-2 was observed in one or more em-
bryos (data not shown). We conclude that, although
EGG-3 degradation may contribute to MBK-2 release,
it may not be the only factor involved.
Discussion
In this study, we report that the cortical protein EGG-3 is
required for MBK-2 localization to the cortex. We dem-
onstrate that (1) EGG-3 forms a complex with MBK-2
in vivo and in vitro, (2) EGG-3 functions as a negative
regulator of MBK-2 during meiosis I, and (3) EGG-3 is
degraded during the meiotic divisions in an APC/C-
and proteasome-dependent manner. We discuss the
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1550Figure 5. Loss of egg-3 Suppresses the Degradation Defect of mat-1 Zygotes by Releasing Active MBK-2 from the Cortex
(A–F) Gonads of live mat-1(ax227) (A–C) or mat-1(ax227);egg-3(RNAi) (D–F) hermaphrodites expressing GFP:MBK-2 (A, D), GFP:MEI-1 (B, E), or
GFP:POS-1 (C, F). Asterisk denotes the position of the spermatheca; dashed circles mark embryos with lower GFP levels. Gut autofluorescence
is visible above oocytes and embryos.
(G) Percent of embryos positive for GFP:MEI-1 or GFP:POS-1 were plotted with respect to position in the uterus of wild-type, mat-1(ax227), and
mat-1(ax227);egg-3(RNAi) hermaphrodites. Ovulation rates were not significantly different between these genotypes (Figure S3).
(H) Kinase assay comparing the kinase activity of GFP:MBK-2 immunoprecipitated from wild-type or mat-1(ax227) worms against a synthetic
peptide (DYRKtide). GFP:MBK-2(K196R) has a mutation in the ATP binding site and is inactive [7]. Loading of GFP:MBK-2 was determined
by immunoblotting with GFP antibody and loading of DYRKtide by Silver Quest staining (Invitrogen). 32P incorporation was detected with a Phos-
phorimager (Amersham). Numbers represent average percent activity with respect to wild-type 6 standard deviation from three independent
experiments.
(I and J) Fixed zygotes from mat-1(ax227);mel-26(RNAi) with (J) or without (I) egg-3(RNAi) and stained with a-MEI-1-Ser92P. Note the cortical
accumulation in mat-1(ax227);mel-26(RNAi).
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Degradation Is Controlled by the Meiotic
Cell Cycle
Live wild-type (A), mat-1(RNAi) (B), or wee-
1.3(RNAi) (C) hermaphrodites expressing
GFP:EGG-3. Eggs with GFP:EGG-3 in cyto-
plasmic puncta are outlined with a dashed
line, and eggs with no GFP:EGG-3 are out-
lined with a dotted line.implications of these findings in the context of the oo-
cyte-to-zygote transition.
Cortical Tethering as a Mechanism to Restrict MBK-2
from Its Cytoplasmic Substrates
EGG-3 contains a predicted protein-tyrosine phospha-
tase (PTP) domain missing certain active site residues
(see [1], accompanying paper in this issue). PTPs with
similar ‘‘natural mutations’’ have been shown to lack
phosphatase activity, although some retain the ability
to bind to phosphorylated substrates [17, 18]. We have
shown that EGG-3 and MBK-2 exist in a complex in
vivo and interact directly in vitro. Because MBK-2 is pre-
dicted to autophosphorylate on tyrosines, an attractive
possibility is that EGG-3 recognizes a phosphorylated
tyrosine in MBK-2. EGG-3, however, also interacts with
kinase-dead MBK-2 synthesized in E. coli, which is pre-
dicted not to contain any phosphorylated tyrosines
(K.C.-C.C., unpublished data). Although EGG-3 and
MBK-2 interact directly in vitro, this interaction may not
be sufficient to localize MBK-2 to the cortex in vivo,
because cortical EGG-3 is not sufficient to recruit
MBK-2 when stabilized in 2-cell and older embryos.
Consistent with this view, we identified two other genes
in our screen required for MBK-2 localization to the cor-
tex. Depletion of these genes by RNAi does not affect
EGG-3 localization to the cortex (K.C.-C.C., unpublished
data), suggesting that these genes are required, in addi-
tion to EGG-3, to anchor MBK-2.
Several lines of evidence support the hypothesis that
cortical anchoring limits MBK-2’s ability to phosphory-
late cytoplasmic targets during meiosis I. First, in wild-
type embryos, appearance of MEI-1-S92P during meio-
sis II correlates with relocalization of GFP:MBK-2 from
the cortex to the cytoplasm [7]. Second, in egg-3 mu-
tants, MBK-2 is constitutively cytoplasmic and MEI-1
is phosphorylated prematurely in meiosis I (as observed
in egg-3(tm1191); mel-26(RNAi); this work). Third, in
mat-1 mutants arrested in meiosis I, GFP:MBK-2remains cortical and degradation of GFP:MEI-1 and
GFP:POS-1 is blocked [7, 11]. Fourth, the mat-1 block
can be reversed by eliminating EGG-3 and forcing
MBK-2 to the cytoplasm (this work).
Cortical tethering of MBK-2 during meiosis I could
inhibit MBK-2 activity directly or indirectly, by reducing
access to cytoplasmic targets. We favor the latter
because GFP:MBK-2 immunoprecipitated from mat-1
mutants is active and because some MEI-1-S92P can
be detected at the cortex in mat-1(ts); mel-26(RNAi)
zygotes. One possibility is that the cortex functions as
a diffusion barrier between MBK-2 and the bulk of its
cytoplasmic targets.
Cell-Cycle Regulation of MBK-2
What releases MBK-2 from the cortex? Starting in ana-
phase of meiosis I, EGG-3 and GFP:MBK-2 localize to
subcortical puncta that invade the cytoplasm during
the second meiotic division. Similar structures have
been observed with a GFP fusion to the membrane pro-
tein caveolin [26], raising the possibility that EGG-3/
MBK-2 are internalized on the surface of endocytosed
vesicles. During internalization, total EGG-3 levels de-
crease and cytoplasmic MBK-2 levels increase. The dy-
namics of EGG-3 degradation resemble those described
for GFP:cyclin B1 [10], a known target of the anaphase-
promoting complex/cyclosome (APC/C) in yeast and
vertebrates [25]. Consistent with being an APC/C target,
EGG-3 degradation depends on two D boxes, the APC/
C subunit mat-1, and the proteasome. We suggest that
APC/C-dependent degradation of EGG-3 is one of the
mechanisms by which the meiotic cell cycle activates
MBK-2. In fact, the finding that the MEI-1 and POS-1
degradation defects of mat-1 mutants can be sup-
pressed by depleting egg-3 suggests that APC/C’s
only essential role in activating MBK-2 is to antagonize
EGG-3.
Stabilization of EGG-3 is not sufficient to recruit MBK-
2 back to the cortex after the zygote stage, suggesting
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1552Figure 7. EGG-3 Is a Likely Target of the Anaphase-Promoting Complex/Cyclosome
(A) Amino acid sequence of EGG-3. PTP domain is underlined, D boxes are marked in red, and the phosphatase active site is green.
(B) List of mutants tested for effect on cortical localization and degradation of GFP:EGG-3.
(C) Images of live embryos expressing GFP fusions as indicated.
(D) Western showing similar expression levels of the wild-type and mutant GFP:EGG-3 fusions. The increased stability of some of the fusions,
as shown in (C), does not result in detectably higher levels in the western, possibly because the increase in 2-cell and later stages is modest
compared to total EGG-3 present in oocytes and early zygotes.that progression through the meiotic divisions also sup-
presses the activity of other factors required for MBK-2
cortical localization. One possibility is that endocytosis
during the meiotic divisions removes several factors at
once from the cortex required for MBK-2 anchoring.
In egg-3;mel-26 mutants, MEI-1-S92P appears pre-
maturely in eggs that have progressed to metaphase I,
but is not observed in oocytes that have not yet been
ovulated. EGG-3-independent mechanisms must there-
fore operate in those earlier stages to keep MBK-2 in-
active. We propose that MBK-2 activation occurs in
two steps: (1) activation of kinase activity during ovula-
tion and/or the first meiotic division by an unknown
mechanism, and (2) release of active MBK-2 from the
cortex during the second meiotic division via APC/C-
dependent internalization and degradation of EGG-3
(and possibly other factors).
Spatial Regulation: A Common Way to Regulate
Kinases in Oocytes?
The transition from oocyte to zygote occurs in the ab-
sence of mRNA transcription and thus must rely on
post-transcriptional mechanisms to change gene activ-
ity. Our studies with MBK-2 illustrate the role of spatial
compartmentalization as an efficient mechanism to
keep an active kinase away from the bulk of its targets
until the right time. A similar mechanism has recently
been implicated in the downregulation of protein kinase
A (PKA) in mouse oocytes [27]. PKA maintains prophasearrest in oocytes before maturation. During maturation,
the PKA catalytic subunit Calpha relocalizes from the
cortex to the cytoplasm, and the regulatory subunit RII
relocalizes from the cortex/cytoplasm to mitochondria
[28, 29]. Elimination of the anchor protein AKAP1 pre-
vents RII relocalization to mitochondria and blocks oo-
cyte maturation, apparently because of excess PKA re-
maining at the cortex [29]. These observations have led
to a model whereby active PKA is downregulated during
maturation by AKAP1, which sequesters the RII subunit
away from cortical targets [27]. The mechanisms that
induce RII relocalization are not known but have been
proposed to be linked to entry into meiotic M phase
[29]. We suggest that internalization of cortical proteins
stimulated by the advancing cell cycle simultaneously
‘‘inactivates’’ and ‘‘activates’’ different sets of kinases
by removing them from (e.g., PKA) or releasing them
to (e.g., MBK-2) their substrates. This reorganization
changes the global landscape of kinase/substrate inter-
actions and irreversibly commits the oocyte to matura-
tion and preparation for embryogenesis.
The EGG-3/MBK-2 Complex Links the Events
of Oocyte Maturation and Egg Activation
In addition to its role in regulating MBK-2 described here,
EGG-3 also functions in egg activation. egg-3 oocytes
undergo maturation, meiosis, and fertilization but do not
form polar bodies or an egg shell, two processes depen-
dent on fertilization (see [1], accompanying paper in this
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1553issue). In contrast, mbk-2 mutants undergo egg activa-
tion, but fail to degrade MEI-1, OMA-1, and germ plasm
proteins, processes dependent on oocyte maturation
[7]. The finding that MBK-2 and EGG-3 exist in a complex
suggests an intimate connection between the egg re-
modeling events triggered by oocyte maturation and
those triggered by egg activation. A cortical complex
with the ability to respond to both the advancing cell cy-
cle and to fertilization may help orchestrate the proper
timing of the many aspects of the oocyte-to-zygote tran-
sition, coordinating loss of germ cell fate with acquisi-
tion of zygotic totipotency. A challenge for the future
will be to understand how cell cycle- and fertilization-
dependent signals converge on the EGG-3/MBK-2 com-
plex. Our finding that the egg activation protein EGG-3
is a negative regulator of MBK-2 that is degraded in an
APC/C-dependent manner offers a first insight into this
process.
Experimental Procedures
Nematode Strains and Temperature Shift Experiments
C. elegans strains (Table S1) were derived from the wild-type Bristol
strain N2 and reared by standard procedures [30]. egg-3(tm1191)
was a gift from S. Mitani (Tokyo Women’s Medical College, National
Bioresource Project of Japan) and is a 480 bp deletion predicted to
result in a termination codon at amino acid 160. tm1191/tm1191 her-
maphrodites do not stain with anti-EGG-3 serum raised against
amino acids 29–49 (see below), confirming that tm1191 is a null.
mat-1(ax227) hermaphrodites were maintained at 16C and shifted
to 25C as L4 larvae.
Transgene Construction and Transformation
All transgenes in this study were driven by the pie-1 promoter and
30UTR for maternal expression [31]. GFP:MBK-2 is described in
[11] and rescues the mbk-2 null allele (pk1427). The egg-3 ORF
was amplified from cDNA and cloned into pID3.01 [31] to create
GFP:EGG-3. D box mutations were generated with QuickChange
site-directed mutagenesis kit (Stratagene) and confirmed by se-
quencing. Isoform C of MBK-2 was amplified from genomic DNA
and cloned into pID2.02 [31] to create MBK-2:6XHis. Microparticle
bombardment [32] was used to generate several independent lines
for each transgene, and a single representative line was selected
for further experiments.
RNAi
Feeding clones corresponding to predicted kinases and phospha-
tases (WORMBASE) were cherry-picked from the Ahringer feeding
library [33], grown in LB + ampicillin (100 mg/ml) at 37C, and spread
on NNGM (nematode nutritional growth medium) + Amp (100 mg/ml)
+ IPTG (80 mg/ml).w30 GFP:MBK-2 L2 worms were incubated on the
plates for 48 hr at 25C before screening with a fluorescence
compound microscope.
For individual RNAi experiments, L4 hermaphrodites were fed at
25C for 24–27 hr before examination, except for rpn-7(RNAi), which
were examined after 16 hr of feeding.
Antibodies
Anti-MBK-2 sera were generated against the N-terminal peptide
CMHSKIPKSPSNES in rabbit (Bethyl Laboratories; used for immuno-
fluorescence) and against recombinant GST:MBK-2 in rabbit (Cova-
nce; used for western). Anti-EGG-3 serum was generated against
N-terminal peptide KWVHSANRRKGHLTPKAPEKK in guinea pig
(Covance). EGG-3 and MBK-2 antibodies blotted against whole
worm extracts identified a prominent band migrating in the expected
size range (Figure 3). Immunofluorescence experiments comparing
staining inwild-type and nullmutants confirmedspecificity (FigureS1).
Worm Extract Preparation
Adult hermaphrodites suspended in ice-cold lysis/homogenization
buffer (50 mM HEPES [pH 7.4], 300 mM KCl, 1 mM MgCl2, 1 mMEGTA, 10% glycerol, 0.5 mM DTT, 0.05% NP-40, and Complete
Mini protease inhibitor tablet [Roche]) were lysed by three freeze-
thaw cycles in liquid nitrogen and vortexing with glass beads
(Sigma) or by grinding with a mortar and pestle. Extracts were cen-
trifuged at 4C, 14,000 rpm for 15 min and 30 min, frozen in liquid
nitrogen, and stored at 280C.
Immunoprecipitations and Western Blotting
Extracts were precleared with protein A-agarose beads coupled to
60 ml of rabbit IgG (1 mg/ml, Sigma) or 10 ml of guinea pig IgG (Sigma).
GFP, MBK-2, and EGG-3 antibodies were coupled to protein A mag-
netic beads (NEB) (GFP) or protein A-agarose (Pierce) (MBK-2, EGG-
3). Beads were incubated with precleared extracts at 4C overnight
and washed three times with ice-cold homogenization buffer. Pre-
cipitates and input were run on a 4%–12% SDS-PAGE (Invitrogen).
The following antibodies (and dilutions) were used in western blot-
ting: anti-MBK-2 (1:2500), anti-EGG-3 (1:5000), anti-PAR-5 (1:500,
gift from A. Golden), anti-GFP (JL-8, 1:1000; BD Biosciences), anti-
FLAG M2 (1:4000, Sigma), anti-GST (1:200, Santa Cruz), anti-tubulin
(E7, 1:1000, Developomental Studies Hybridoma Bank), HRP-conju-
gated anti-rabbit (1:10,000, Pharmacia), anti-mouse (1:10,000,
Amersham Pharmacia), and anti-guinea pig (1:10,000, Sigma).
DYRKtide Kinase Assay
Kinase assays were performed as described in [34]. GFP:MBK-2
immunoprecipitates were incubated with DYRKtide/Woodtide
(KKISGRLSPIMTEQ, 50 mM final concentration UBI) in kinase buffer
(10 mM MgCl2, 50 mM Tris-HCl [pH 7.5], 0.1 mM EGTA, 0.1% beta-
mercaptoethanol [BME]) with [32P]ATP (Amersham Pharmacia) for
10 min at 30C. Reactions were stopped with 13NuPage LDS Sample
Buffer (Invitrogen) and BME (5% v/v). Samples were boiled for 5 min,
beads removed with a magnet, and supernatants were separated on
a 16% Tricine gel (Invitrogen). DYRKtide was visualized with the Sil-
verQuest silver staining kit (Invitrogen). 32P incorporation was de-
tected in the same gel by Phosphorimager (Amersham Pharmacia).
Percent activity (Figure 5H) was calculated by measuring 32P in-
corporation with ImageQuant 5.2 (Molecular Dynamics) normalized
for the amount of immunoprecipitated GFP:MBK-2 as measured
by western (ImageJ gel tools) and expressed as percent of wild-type
activity.
GST Pull-Down Assay
mbk-2 and egg-3 ORFs were amplified from cDNA, cloned into
pDEST-15 (GST fusions) or pKC5.02 (FLAG fusions) to create
amino-terminal fusions, and expressed in BL21(DE3) gold (Invitro-
gen). Glutathione-Sepharose 4B beads (Amersham Pharmacia)
were incubated with GST extracts at 4C for 2 hr in PBST (phos-
phate-buffered saline with 1% Triton X-100), washed, incubated
with crude FLAG extracts in binding buffer (20 mM HEPES [pH
7.6], 200 mM NaCl, 1 mM EDTA, 6% glycerol, 0.5 mM DTT, 0.1%
NP-40, and Complete Mini protease inhibitor tablet [Roche]) at 4C
for 2 hr, and washed. The bound proteins were eluted by boiling in
23 LDS sample buffer (Invitrogen) and subjected to 4%–12%
SDS-PAGE (Invitrogen) for western blot analysis.
Immunofluorescence, Microscopy, and Quantification
Embryos were prepared as in [7]. Primary antibodies used were
mouse monoclonal anti-GFP (3E6, 1:100; Molecular Probes), rabbit
anti-MBK-2 (1:10,000, Bethyl Laboratories), guinea pig anti-EGG-3
(1:10,000), rabbit anti-MEI-1-Ser92P (1:2000) [7], and mouse anti-His
(1:10,000; Sigma). Secondary antibodies were Cy3 goat anti-mouse
(1:200, Jackson ImmunoResearch), Alexa 568 goat anti-rabbit (1:250,
Molecular Probes), and Alexa 488/Alexa 568 goat anti-guinea pig
(1:200, Molecular Probes). Images were acquired with a Hamamatsu
ORCA-ER digital camera attached to a Zeiss Axioplan 2, processed
with IPLab software (Scanalytics, Inc.) and Photoshop CS. Values
in Figure 2E were obtained by measuring pixel intensity (background
subtracted) in a 503 50 pixel square within the embryo (cytoplasmic
GFP:MBK-2) or a 720 3 520 pixel rectangle surrounding the total
embryo (total GFP:MBK-2 and total EGG-3) for a minimum of 3 fixed
embryos from each stage. Values were normalized such that the
maximum intensity for each series equals 1. Values in Figure 4C
were obtained from time-lapse images by computing average GFP
fluorescence for three 25-pixel squares placed on (1) a preovulation
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1554oocyte, (2) a newly ovulated egg, and (3) a 2-cell or older embryo
(background), avoiding spindle and nuclei. For each time point,
background was subtracted and GFP:MEI-1 intensity in the newly
ovulated egg was expressed as a fraction of GFP:MEI-1 in the nono-
vulated egg (to correct for bleaching during the course of the exper-
iment).
Supplemental Data
Three figures and one table are available at http://www.current-
biology.com/cgi/content/full/17/18/1545/DC1/.
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